Back to search results

A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

SVT · Thrombosis · Superficial Vein Thrombosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The Ottawa Hospital, Ottawa, Ontario, Canada

    Contact: Study coordinator (Veronica Bates, BSc, CCRP) · vebates@ohri.ca · 613-737-8899
    Contact: Principal Investigator (Tzu-Fei Wang, MD, MPH)

  • Hopital Montfort, Ottawa, Ontario, Canada

    Contact: Study coordinator (Christine-Nadia Compas) · christinencompas@montfort.on.ca · 613-746-4621
    Contact: Principal Investigator (Miriam Kimptom, MD,MSc,FRCPC)
Study leads

  • Tzu-Fei Wang, MD,MPH

    Principal Investigator

    Ottawa Hospital Research Institute

View source on ClinicalTrials.gov(opens in a new tab)